The process improvement of manufacturing active pharmaceutical ingredients

被引:0
|
作者
Chen, Chiwei [1 ]
Pao, Lu-Sheng [2 ]
Lei, Hong [1 ]
Hsieh, Meng-Zhi [3 ]
机构
[1] Zhaoqing Univ, Coll Econ & Management, Zhaoqing, Guangdong, Peoples R China
[2] Sanming Univ, Coll Econ & Management, Fujian, Peoples R China
[3] Tajen Univ, Dept Pharm, Pingtung, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
105
引用
下载
收藏
页码:57 / 58
页数:2
相关论文
共 50 条
  • [41] Challenges in Nanogrinding of Active Pharmaceutical Ingredients
    Bitterlich, Andre
    Laabs, Christina
    Busmann, Eike
    Grandeury, Arnaud
    Juhnke, Michael
    Bunjes, Heike
    Kwade, Arno
    CHEMICAL ENGINEERING & TECHNOLOGY, 2014, 37 (05) : 840 - 846
  • [42] Asymmetric synthesis of active pharmaceutical ingredients
    Farina, Vittorio
    Reeves, Jonathan T.
    Senanayake, Chris H.
    Song, Jinhua J.
    CHEMICAL REVIEWS, 2006, 106 (07) : 2734 - 2793
  • [43] Influence of Process Parameters on the Heterogeneous Nucleation of Active Pharmaceutical Ingredients onto Excipients
    Bueno, Raquel Arribas
    Crowley, Clare M.
    Hodnett, Benjamin K.
    Hudson, Sarah
    Davern, Peter
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2017, 21 (04) : 559 - 570
  • [44] Validation and implementation of in-process control HPLC assays for active pharmaceutical ingredients
    Wrezel, PW
    Chion, I
    Hussain, MS
    LC GC NORTH AMERICA, 2004, 22 (10) : 1006 - +
  • [45] Monitoring and quality improvement of pharmaceutical glass container's manufacturing process
    Rodriguez, Fco Javier
    Meca, Fco Javier
    Jimenez, Jose A.
    Bueno, Emilio J.
    IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT, 2008, 57 (03) : 584 - 590
  • [46] Managing emissions of active pharmaceutical ingredients from manufacturing facilities: An environmental quality standard approach
    Murray-Smith, Richard J.
    Coombe, Vyvyan T.
    Gronlund, Marie Haag
    Waern, Fredrik
    Baird, James A.
    INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT, 2012, 8 (02) : 320 - 330
  • [47] Qualification and validation in the manufacture of active pharmaceutical ingredients and pharmaceutical products
    Metzger, K
    PHARMAZEUTISCHE INDUSTRIE, 1999, 61 (10): : 945 - 952
  • [48] Handling of highly active pharmaceutical ingredients and intermediates in the pharmaceutical industry
    Miedinger, David
    SAFETY AND HEALTH AT WORK, 2022, 13 : S39 - S39
  • [49] Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients
    LaPorte, Thomas L.
    Wang, Chenchi
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (06) : 738 - 745
  • [50] A Process for the Formation of Nanocrystals of Active Pharmaceutical Ingredients with Poor Aqueous Solubility in a Nanoporous Substrate
    O'Mahony, Marcus
    Leung, Allen K.
    Ferguson, Steven
    Trout, Bernhardt L.
    Myerson, Allan S.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2015, 19 (09) : 1109 - 1118